- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Respiratory syncytial virus (RSV)
- Meeting Date: July 2025
- Public Summary Document (PSD) November 2024 July 2025 PBAC Meetings - (PDF 2MB)
- Public Summary Document (PSD) November 2024 July 2025 PBAC Meetings - (Word 1.4MB)
Respiratory Syncytial Virus Vaccine – July 2025
Respiratory Syncytial Virus Vaccine; Injection (0.5 mL); Abrysvo® – November 2024 – July 2025
Last updated
9 July 2025